Yuanyuan Zhang1, Xiaoliang Liu1, Haiming Gao1, Rong He1, Yanyan Zhao2. 1. Department of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China. 2. Department of Clinical Genetics, Shengjing Hospital of China Medical University, Shenyang, China. yyzhao@sj-hospital.org.
Abstract
BACKGROUND: 22q11.2 variation is a significant genetic factor relating to development delay and/or intellectual disability. However, the prevalence, genetic characteristics and clinical phenotype in Chinese patients are unknown. METHODS: In total 6034 patients with development delay and/or intellectual disability were screened by multiplex ligation-dependent probe amplification (MLPA) P245 and G-band karyotyping. The positive patients with 22q11.2 imbalance were confirmed by MLPA P250 assay. RESULTS: 52 (0.86%) patients were found to carry different levels of 22q11.2 variations, in which 37 cases (71.2%) had heterozygous deletions, whereas 15 (28.8%) had heterogeneous duplications. 34 cases (65.4%) carried typical imbalance from low copy repeat (LCR) 22 A to D. The other cases had atypical variations, relating to LCR22 A-B, LCR22 C-D, LCR22 B-D, LCR22 D-E, LCR22 E-F and LCR22 B-F region. The phenotypes of these 52 patients were variable, including development delay, language delay, facial anomalies, heart defects, psychiatric/behavior problems, epilepsy, periventricular leukomalacia, hearing impairment, growth delay etc. CONCLUSION: These data revealed the prevalence and variability of 22q11.2 genomic imbalance in Chinese patients with development delay and/or intellectual disability. It suggested that genetic detection of 22q11.2 is necessary, especially for the patients with mental retardation and development disorders, which deserves the attention of all pediatricians in their daily work.
BACKGROUND: 22q11.2 variation is a significant genetic factor relating to development delay and/or intellectual disability. However, the prevalence, genetic characteristics and clinical phenotype in Chinese patients are unknown. METHODS: In total 6034 patients with development delay and/or intellectual disability were screened by multiplex ligation-dependent probe amplification (MLPA) P245 and G-band karyotyping. The positive patients with 22q11.2 imbalance were confirmed by MLPA P250 assay. RESULTS: 52 (0.86%) patients were found to carry different levels of 22q11.2 variations, in which 37 cases (71.2%) had heterozygous deletions, whereas 15 (28.8%) had heterogeneous duplications. 34 cases (65.4%) carried typical imbalance from low copy repeat (LCR) 22 A to D. The other cases had atypical variations, relating to LCR22 A-B, LCR22 C-D, LCR22 B-D, LCR22 D-E, LCR22 E-F and LCR22 B-F region. The phenotypes of these 52 patients were variable, including development delay, language delay, facial anomalies, heart defects, psychiatric/behavior problems, epilepsy, periventricular leukomalacia, hearing impairment, growth delay etc. CONCLUSION: These data revealed the prevalence and variability of 22q11.2 genomic imbalance in Chinese patients with development delay and/or intellectual disability. It suggested that genetic detection of 22q11.2 is necessary, especially for the patients with mental retardation and development disorders, which deserves the attention of all pediatricians in their daily work.
Entities:
Keywords:
22q11.2 variation; Clinical phenotype; Development delay; MLPA
Authors: Tamim H Shaikh; Ronald J O'Connor; Mary Ella Pierpont; James McGrath; April M Hacker; Manjunath Nimmakayalu; Elizabeth Geiger; Beverly S Emanuel; Sulagna C Saitta Journal: Genome Res Date: 2007-03-09 Impact factor: 9.043
Authors: T H Shaikh; H Kurahashi; S C Saitta; A M O'Hare; P Hu; B A Roe; D A Driscoll; D M McDonald-McGinn; E H Zackai; M L Budarf; B S Emanuel Journal: Hum Mol Genet Date: 2000-03-01 Impact factor: 6.150
Authors: Jennifer K Forsyth; Daniel Nachun; Michael J Gandal; Daniel H Geschwind; Ariana E Anderson; Giovanni Coppola; Carrie E Bearden Journal: Biol Psychiatry Date: 2019-07-11 Impact factor: 13.382